Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Cancer Causes & Control
Published in: Cancer Causes & Control 8/2014

01-08-2014 | Erratum

Erratum to: Childhood acute leukemia, maternal beverage intake during pregnancy, and metabolic polymorphisms

Authors: Audrey Bonaventure, Jérémie Rudant, Stéphanie Goujon-Bellec, Laurent Orsi, Guy Leverger, André Baruchel, Yves Bertrand, Brigitte Nelken, Marlène Pasquet, Gérard Michel, Nicolas Sirvent, Pierre Bordigoni, Stéphane Ducassou, Xavier Rialland, Diana Zelenika, Denis Hémon, Jacqueline Clavel

Published in: Cancer Causes & Control | Issue 8/2014

Login to get access

Excerpt

Unfortunately, the original publication of the article includes an error in the column labeling (Table 2). The correct labels for the column headings should read (left to right): “Controls n = 1,681”, “all AL n = 764”, “ALL n = 648”, “AML n = 101”. …
Metadata
Title
Erratum to: Childhood acute leukemia, maternal beverage intake during pregnancy, and metabolic polymorphisms
Authors
Audrey Bonaventure
Jérémie Rudant
Stéphanie Goujon-Bellec
Laurent Orsi
Guy Leverger
André Baruchel
Yves Bertrand
Brigitte Nelken
Marlène Pasquet
Gérard Michel
Nicolas Sirvent
Pierre Bordigoni
Stéphane Ducassou
Xavier Rialland
Diana Zelenika
Denis Hémon
Jacqueline Clavel
Publication date
01-08-2014
Publisher
Springer International Publishing
Published in
Cancer Causes & Control / Issue 8/2014
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-014-0403-5

Other articles of this Issue 8/2014

Cancer Causes & Control 8/2014 Go to the issue

Original paper

Different time trends by gender for the incidence of Hodgkin’s lymphoma among young adults in the USA: a birth cohort phenomenon

Original paper

Validity of a self-administered food frequency questionnaire in the estimation of heterocyclic aromatic amines

Original paper

Application of the Rosner–Wei risk-prediction model to estimate sexual orientation patterns in colon cancer risk in a prospective cohort of US women

Original paper

To what extent is women’s economic situation associated with cancer screening uptake when nationwide screening exists? A study of breast and cervical cancer screening in France in 2010

Brief report

Serum uric acid levels and cancer mortality risk among males in a large general population-based cohort study

Original paper

Age at first childbirth and oral contraceptive use are associated with risk of androgen receptor-negative breast cancer: the Malmö Diet and Cancer Cohort
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits